The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench

被引:484
作者
Bacon, MC
von Wyl, V
Alden, C
Sharp, G
Robison, E
Hessol, N
Gange, S
Barranday, Y
Holman, S
Weber, K
Young, MA
机构
[1] NIAID, DAIDS, BSP, Epidemiol Branch,Div AIDS, Bethesda, MD 20817 USA
[2] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA
[3] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Montefiore Med Ctr, Bronx, NY 10467 USA
[7] Univ So Calif, Med Ctr, Los Angeles, CA USA
[8] SUNY Hlth Sci Ctr, Brooklyn, NY USA
[9] John H Stroger Hosp Cook Cty, Chicago, IL USA
关键词
D O I
10.1128/CDLI.12.9.1013-1019.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 25 条
[1]   The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy [J].
Anastos, K ;
Barrón, Y ;
Cohen, MH ;
Greenblatt, RM ;
Minkoff, H ;
Levine, A ;
Young, M ;
Gange, SJ .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (04) :256-264
[2]   Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease [J].
Anastos, K ;
Barrón, Y ;
Miotti, P ;
Weiser, B ;
Young, M ;
Hessol, N ;
Greenblatt, RM ;
Cohen, M ;
Augenbraun, M ;
Levine, A ;
Muñoz, A .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (17) :1973-1980
[3]   Incident hepatitis C virus in women with human immunodeficiency virus infection [J].
Augenbraun, M ;
Goedert, JJ ;
Thomas, D ;
Feldman, J ;
Seaberg, EC ;
French, AL ;
Robison, E ;
Nowicki, M ;
Terrault, N .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (10) :1357-1364
[4]   The Women's Interagency HIV Study [J].
Barkan, SE ;
Melnick, SL ;
Preston-Martin, S ;
Weber, K ;
Kalish, LA ;
Miotti, P ;
Young, M ;
Greenblatt, R ;
Sacks, H ;
Feldman, J .
EPIDEMIOLOGY, 1998, 9 (02) :117-125
[5]   Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women [J].
Battle-Miller, K ;
Eby, CA ;
Landay, AL ;
Cohen, MH ;
Sha, BE ;
Baum, LL .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (04) :439-447
[6]  
*CDCP, 2002, HIV AIDS SURVEILLANC, V13, P21
[7]  
Centers for Disease Control and Prevention, 1996, HIV AIDS SURVEILLANC, V8, P2
[8]   Medically eligible women who do not use HAART: The importance of abuse, drug use, and race [J].
Cohen, MH ;
Cook, JA ;
Grey, D ;
Young, M ;
Hanau, LH ;
Tien, P ;
Levine, AM ;
Wilson, TE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (07) :1147-1151
[9]   Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models [J].
Cole, SR ;
Hernán, MA ;
Robins, JM ;
Anastos, K ;
Chmiel, J ;
Detels, R ;
Ervin, C ;
Feldman, J ;
Greenblatt, R ;
Kingsley, L ;
Lai, SH ;
Young, M ;
Cohen, M ;
Muñoz, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (07) :687-694
[10]   Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women [J].
Cook, JA ;
Cohen, MH ;
Grey, D ;
Kirstein, L ;
Burke, J ;
Anastos, K ;
Palacio, H ;
Richardson, J ;
Wilson, TE ;
Young, M .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (01) :82-87